Two Psoriasis Therapies Grab CHMP Backing For European Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Novartis’s Cosentyx and Celgene’s Otezla are expected to be approved and launched in Europe in early 2015 for the dermatological indication.